Literature DB >> 19562461

Helicobacter pylori and gastric cancer.

Hidekazu Suzuki1, Eisuke Iwasaki, Toshifumi Hibi.   

Abstract

Helicobacter pylori is now well known as an important pathogen related to the development of gastric cancer. However, some clinicians still doubt the causal association of H. pylori with the development of gastric cancer. To summarize the recent clinical data on the link between H. pylori and gastric cancer, we reviewed related articles published over the past 3 years, after the award of the Nobel Prize for Physiology or Medicine to Drs. J.R. Warren and B.J. Marshall for the first culture and isolation of H. pylori and the investigation of their relevance to peptic ulcer disease. This updated summary of the relationship between H. pylori and gastric cancer highlights the strong link between the organism and the development of gastric cancer, and suggests eradication of this bacterial infection as a possible prophylactic measure against the development of this lethal malignancy. At present, clinicians and researchers in the field emphasize the strong need for H. pylori eradication from the human stomach.

Entities:  

Mesh:

Year:  2009        PMID: 19562461     DOI: 10.1007/s10120-009-0507-x

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  59 in total

1.  Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.

Authors:  Takeshi Matsuhisa; Takashi Kawai; Tatsuhiro Masaoka; Hidekazu Suzuki; Masayoshi Ito; Yo Kawamura; Kengo Tokunaga; Masayuki Suzuki; Tetsuya Mine; Shin-ichi Takahashi; Nobuhiro Sakaki
Journal:  Helicobacter       Date:  2006-06       Impact factor: 5.753

2.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

3.  Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.

Authors:  Shizuka Sasazuki; Manami Inoue; Motoki Iwasaki; Tetsuya Otani; Seiichiro Yamamoto; Shinobu Ikeda; Tomoyuki Hanaoka; Shoichiro Tsugane
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-07       Impact factor: 4.254

4.  Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

Authors:  Carlos A González; Guillem Pera; Antonio Agudo; H Bas Bueno-de-Mesquita; Marco Ceroti; Heiner Boeing; Mandy Schulz; Giuseppe Del Giudice; Mario Plebani; Fátima Carneiro; Franco Berrino; Carlotta Sacerdote; Rosario Tumino; Salvatore Panico; Göran Berglund; Henrik Simán; Göran Hallmans; Roger Stenling; Carmen Martinez; Miren Dorronsoro; Aurelio Barricarte; Carmen Navarro; José R Quiros; Naomi Allen; Timothy J Key; Sheila Bingham; Nicholas E Day; Jakob Linseisen; Gabriele Nagel; Kim Overvad; Majken K Jensen; Anja Olsen; Anne Tjønneland; Frederike L Büchner; Petra H M Peeters; Mattijs E Numans; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Dimitrios Roukos; Antonia Trichopoulou; Theodora Psaltopoulou; Eiliv Lund; Corinne Casagrande; Nadia Slimani; Mazda Jenab; Elio Riboli
Journal:  Int J Cancer       Date:  2006-05-15       Impact factor: 7.396

5.  Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.

Authors:  Svein Hansen; Stein Emil Vollset; Mohammad H Derakhshan; Valerie Fyfe; Kjetil K Melby; Steinar Aase; Egil Jellum; Kenneth E L McColl
Journal:  Gut       Date:  2007-02-22       Impact factor: 23.059

6.  Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori.

Authors:  Shoji Suzuki; Hidekazu Suzuki; Toshihiro Nishizawa; Fumihiko Kaneko; Sumire Ootani; Hiroe Muraoka; Yoshimasa Saito; Intetsu Kobayashi; Toshifumi Hibi
Journal:  Digestion       Date:  2009-01-14       Impact factor: 3.216

Review 7.  Helicobacter pylori: present status and future prospects in Japan.

Authors:  Hidekazu Suzuki; Toshifumi Hibi; Barry James Marshall
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

8.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

Authors:  A Nomura; G N Stemmermann; P H Chyou; I Kato; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

9.  Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan: comprehensive analysis of 207 polymorphisms of 11 cytokine genes.

Authors:  Hiroshi Seno; Kiichi Satoh; Shingo Tsuji; Takayuki Shiratsuchi; Yosuke Harada; Nobuyuki Hamajima; Kentaro Sugano; Sunao Kawano; Tsutomu Chiba
Journal:  J Gastroenterol Hepatol       Date:  2007-05       Impact factor: 4.029

10.  Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population.

Authors:  Heriberto Medina-Franco; Antonio Ramos-De la Medina; Gloria Vizcaino; Jose Luis Medina-Franco
Journal:  Ann Surg Oncol       Date:  2007-06-05       Impact factor: 5.344

View more
  45 in total

1.  Overlap syndrome of functional dyspepsia and irritable bowel syndrome - are both diseases mutually exclusive?

Authors:  Hidekazu Suzuki; Toshifumi Hibi
Journal:  J Neurogastroenterol Motil       Date:  2011-10-31       Impact factor: 4.924

2.  Identification of gastric cancer risk markers that are informative in individuals with past H. pylori infection.

Authors:  Sohachi Nanjo; Kiyoshi Asada; Satoshi Yamashita; Takeshi Nakajima; Kazuyuki Nakazawa; Takao Maekita; Masao Ichinose; Toshiro Sugiyama; Toshikazu Ushijima
Journal:  Gastric Cancer       Date:  2012-01-12       Impact factor: 7.370

3.  Red meat consumption and stomach cancer risk: a meta-analysis.

Authors:  Peng Song; Ming Lu; Qin Yin; Lei Wu; Dong Zhang; Bo Fu; Baolin Wang; Qinghong Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-29       Impact factor: 4.553

4.  ABC screening for gastric cancer is not applicable in a Japanese population with high prevalence of atrophic gastritis.

Authors:  Tadashi Shimoyama; Masahiko Aoki; Yoshihiro Sasaki; Masashi Matsuzaka; Shigeyuki Nakaji; Shinsaku Fukuda
Journal:  Gastric Cancer       Date:  2012-01-27       Impact factor: 7.370

5.  High FNDC1 expression correlates with poor prognosis in gastric cancer.

Authors:  Muxiao Zhong; Yijie Zhang; Fangfang Yuan; Yao Peng; Jingjing Wu; Jiawei Yuan; Wei Zhu; Yali Zhang
Journal:  Exp Ther Med       Date:  2018-09-12       Impact factor: 2.447

6.  The association between GSTM1 polymorphism and gastric cancer risk: a meta-analysis.

Authors:  Yu Zhu; Qian He; Jing Wang; Hai-Feng Pan
Journal:  Mol Biol Rep       Date:  2011-05-08       Impact factor: 2.316

Review 7.  Gastric cancer stem cells: a novel therapeutic target.

Authors:  Shree Ram Singh
Journal:  Cancer Lett       Date:  2013-04-10       Impact factor: 8.679

8.  The association between interleukin-10-592 polymorphism and gastric cancer risk: a meta-analysis.

Authors:  Yu Zhu; Jing Wang; Qian He; Jun-Qing Zhang
Journal:  Med Oncol       Date:  2010-01-20       Impact factor: 3.064

9.  Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin.

Authors:  Makoto Sasaki; Naotaka Ogasawara; Keiko Utsumi; Naohiko Kawamura; Tskeshi Kamiya; Hiromi Kataoka; Satoshi Tanida; Tsutomu Mizoshita; Kunio Kasugai; Takashi Joh
Journal:  J Clin Biochem Nutr       Date:  2010-06-17       Impact factor: 3.114

10.  Post-infectious Functional Dyspepsia - A Novel Disease Entity among Functional Gastrointestinal Disorders - Relation to Helicobacter pylori Infection? (Neurogastroenterol Motil 2009;21:832-e56).

Authors:  Hidekazu Suzuki
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.